Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP4F12 |
| Upstream (Parents) |
|---|
| (<<) GCDH → CYP4F12 |
| (<<) SRD5A1 → CYP4F12 |
| (<<) CYP4F3 → CYP4F12 |
| (<<) NAT2 → CYP4F12 |
| (<<) GPT → CYP4F12 |
| Downstream (Children) |
|---|
| CYP4F12 → NPPA (>>) |
| CYP4F12 → PVRL3 (>>) |
| CYP4F12 → MCOLN3 (>>) |
| CYP4F12 → SOX2 (>>) |
| CYP4F12 → GULP1 (>>) |
| CYP4F12 → CTNNA3 (>>) |
| CYP4F12 → ADCY10 (>>) |
| CYP4F12 → DGCR5 (>>) |
| CYP4F12 → FUT5 (>>) |
| CYP4F12 → TAS2R13 (>>) |
| CYP4F12 → RHCE (>>) |
| CYP4F12 → TBCD (>>) |
